
ELV
Elevance Health Inc.
$317.89
+$4.18(+1.33%)
63
Overall
100
Value
27
Tech
--
Quality
Market Cap
$70.64B
Volume
1.46M
52W Range
$273.71 - $542.22
Target Price
$359.06
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $79.2B | $84.9B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | ||
Total Revenue | $79.2B | $84.9B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | ||
OPERATING EXPENSES | ||||||||||||
Selling, General & Administrative | $12.5B | $12.6B | $12.7B | $14.0B | $13.4B | $17.4B | $15.9B | $17.7B | $20.1B | $20.0B | ||
General & Administrative Expenses | $11.1B | $11.2B | $11.3B | -- | -- | -- | -- | -- | -- | -- | ||
Salaries & Wages | $148.2M | $164.6M | $170.0M | $226.0M | -- | $283.0M | $255.0M | -- | -- | -- | ||
Depreciation & Amortization | -- | -- | -- | -- | $-338.0M | -- | -- | -- | -- | -- | ||
Depreciation & Amortization | $515.6M | $576.0M | $601.0M | $652.0M | -- | $638.0M | $668.0M | -- | -- | -- | ||
Amortization | $230.1M | $192.3M | $169.0M | $358.0M | $338.0M | $361.0M | $441.0M | $767.0M | $885.0M | $580.0M | ||
OPERATING INCOME | ||||||||||||
Operating income | $4.7B | $4.7B | $4.0B | $5.1B | -- | $-4.3B | $-5.0B | $-6.8B | $-17.9B | $-22.9B | ||
NON-OPERATING ITEMS | ||||||||||||
Other Income/Expense | $99.9M | $147.1M | $35.0M | $29.0M | $-2.8B | $-10.4B | $-2.0M | $15.0B | $19.5B | $-201.0M | ||
SPECIAL ITEMS | ||||||||||||
Special Income Charges | -- | $19.5M | $19.5M | $5.0M | $2.0M | $36.0M | $99.0M | $35.0M | $446.0M | $72.0M | ||
Impairment of Capital Assets | -- | $19.5M | $19.5M | -- | -- | $198.0M | $73.0M | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
Pre-Tax Income | $4.6B | $4.6B | $4.0B | $5.1B | $6.0B | $6.2B | $7.9B | $7.6B | $7.7B | $7.9B | ||
INCOME TAX | ||||||||||||
Tax Provision | $2.1B | $2.1B | $121.0M | $1.3B | $1.2B | $1.7B | $1.8B | $1.7B | $1.7B | $1.9B | ||
NET INCOME | ||||||||||||
Net Income | $2.6B | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | ||
Net Income (Continuing Operations) | $2.6B | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.1B | $5.9B | $6.0B | $6.0B | ||
Net Income (Discontinued Operations) | $2.6B | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | ||
Net Income (Common Stockholders) | $2.5B | $2.4B | $3.8B | $3.7B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | ||
Normalized Income | $3.1B | $3.1B | $2.6B | $4.0B | $4.7B | -- | -- | -- | -- | -- | ||
TOTALS | ||||||||||||
Total Expenses | $-74.5B | $-80.3B | $-86.1B | $-87.0B | $-98.2B | $-115.6B | $-130.7B | $-149.0B | $-163.6B | $-169.1B | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $263.0M | $262.9M | $261.5M | $258.1M | $255.5M | $250.8M | $243.8M | $240.0M | $235.9M | $231.7M | ||
Average Shares Outstanding (Diluted) | $272.9M | $268.1M | $267.8M | $264.2M | $260.3M | $254.3M | $246.8M | $242.8M | $237.4M | $232.9M | ||
Shares Outstanding | $261.4M | $264.4M | $255.7M | $257.0M | $252.3M | $244.9M | $241.3M | $237.5M | $232.7M | $227.4M | ||
Basic EPS | $9.73 | $9.39 | $14.7 | $14.53 | $18.81 | $18.23 | $25.04 | $25.1 | $25.38 | $25.81 | ||
Basic EPS (Continuing Operations) | $9.73 | $9.39 | $14.7 | $14.53 | $18.81 | $18.23 | $25.04 | $25.1 | $25.38 | $25.81 | ||
Diluted EPS | $9.38 | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.81 | $25.22 | $25.68 | ||
Diluted EPS (Continuing Operations) | $9.38 | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.81 | $25.22 | $25.68 | ||
Dividend Per Share | $2.5 | $2.6 | $2.7 | $3 | $3.2 | $3.8 | $5.12 | $5.12 | $5.92 | -- | ||
OTHER METRICS | ||||||||||||
Ceded Premiums | $96.0M | $83.4M | $45.0M | $51.0M | $45.0M | $79.0M | $74.0M | $64.0M | $61.0M | $66.0M | ||
Fees And Commissions | -- | -- | -- | -- | $6.2B | -- | -- | -- | -- | -- | ||
Gross Premiums Written | $73.5B | $78.9B | $83.8B | $85.2B | $94.8B | $104.1B | $117.4B | $133.2B | $142.9B | $144.2B | ||
Minority Interests | $4.6B | $4.6B | $4.0B | $5.1B | -- | $6.2B | $9.0M | $6.0M | $-4.0M | $9.0M | ||
Net Investment Income | $686.9M | $779.5M | $585.0M | $959.0M | $1.0B | $841.0M | $1.4B | $1.5B | $1.8B | $2.1B | ||
Net Premiums Written | $-73.5B | $-78.9B | $-83.8B | $-85.2B | $-97.0B | $-104.1B | $-117.4B | $-133.2B | $-142.9B | $-144.2B | ||
Net Realized Gain Loss On Investments | $9.3M | $220.1M | $-282.0M | $-11.0M | $-2.0M | $-36.0M | $-21.0M | -- | -- | -- | ||
Other Gand A | $11.1B | $11.2B | $11.3B | -- | -- | -- | -- | -- | -- | -- | ||
Selling Expense | $1.4B | $1.4B | $1.4B | -- | -- | -- | -- | -- | -- | -- | ||
Total Premiums Earned | $73.5B | $78.9B | $83.8B | $85.2B | $94.2B | $104.1B | $117.4B | $133.2B | $142.9B | $144.2B | ||
Intexp | $653.0M | $723.0M | $739.0M | $753.0M | $746.0M | $784.0M | $798.0M | $851.0M | $1.0B | -- | ||
Othspecchg | -- | -- | -- | $5.0M | $-2.0M | $29.0M | $26.0M | -- | $1.0B | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ELV | $317.89 | +1.3% | 1.46M |
3 | ||||
4 | ||||
5 | ||||
6 |